These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. Hiatt WR, Creager MA, Amato A, Brass EP. J Cardiopulm Rehabil Prev; 2011 Nov; 31(2):125-32. PubMed ID: 20861750 [Abstract] [Full Text] [Related]
4. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C. Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005 [Abstract] [Full Text] [Related]
5. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial. Dal Lago A, De Martini D, Flore R, Gaetani E, Gasbarrini A, Gerardino L, Pola R, Santoliquido A, Serricchio M, Tondi P, Nolfe G. Drugs Exp Clin Res; 1999 Nov; 25(1):29-36. PubMed ID: 10337502 [Abstract] [Full Text] [Related]
6. [Treatment of chronic arterial occlusive disease of the lower limbs with propionyl-1-carnitine in elderly patients]. Terranova R, Luca S. Minerva Med; 2001 Feb; 92(1):61-6. PubMed ID: 11317141 [Abstract] [Full Text] [Related]
8. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II. Riccioni C, Sarcinella R, Palermo G, Izzo A, Liguori M, Koverech A, Messano M, Virmani A. Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129 [Abstract] [Full Text] [Related]
14. Levo-propionyl-carnitine improves the effectiveness of supervised physical training on the absolute claudication distance in patients with intermittent claudication. Andreozzi GM, Leone A, Laudani R, Martin R, Deinit G, Cataldi V. Angiology; 2008 Aug; 59(1):84-9. PubMed ID: 18319227 [Abstract] [Full Text] [Related]